Novartis Oncology CEO, Bruno Strigini, To Retire – Quick Facts | Markets Insider
(RTTNews) – Novartis (NVS) announced that Bruno Strigini, CEO Novartis Oncology, has decided to retire from the company and the industry for personal reasons. He will resign from the Executive Committee by December 31, 2017 and will fully handover in early 2018. Novartis said it will announce the successor for Bruno Strigini in due time.
Name: Bruno Strigini
Continent: Europe
Country: Germany
Company: Novartis Oncology
Branch: Healthcare
Position: CEO
Reason: Retired
Announcement Date: December 14, 2017, 11:00pm
Resignation Date: December 14, 2017, 11:00pm